NASDAQ: MLEC

Moolec Science Sa Stock Forecast, Predictions & Price Target

The consensus among 1 Wall Street analyst covering (NASDAQ: MLEC) stock is to Strong Buy MLEC stock.

Out of 1 analyst, 1 (100%) are recommending MLEC as a Strong Buy, 0 (0%) are recommending MLEC as a Buy, 0 (0%) are recommending MLEC as a Hold, 0 (0%) are recommending MLEC as a Sell, and 0 (0%) are recommending MLEC as a Strong Sell.

If you're new to stock investing, here's how to buy Moolec Science Sa stock.

(NASDAQ: MLEC) Moolec Science Sa's forecast annual revenue growth rate of 102.36% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.96%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.23%.

Moolec Science Sa's revenue in 2024 is $2,897,213.On average, 1 Wall Street analysts forecast MLEC's revenue for 2024 to be $141,991,043, with the lowest MLEC revenue forecast at $141,991,043, and the highest MLEC revenue forecast at $141,991,043. On average, 1 Wall Street analysts forecast MLEC's revenue for 2025 to be $294,499,941, with the lowest MLEC revenue forecast at $294,499,941, and the highest MLEC revenue forecast at $294,499,941.

In 2026, MLEC is forecast to generate $992,810,388 in revenue, with the lowest revenue forecast at $992,810,388 and the highest revenue forecast at $992,810,388.

According to 1 Wall Street analyst that have issued a 1 year MLEC price target, the average MLEC price target is $6.00, with the highest MLEC stock price forecast at $6.00 and the lowest MLEC stock price forecast at $6.00.

The Wall Street analyst predicted that Moolec Science Sa's share price could reach $6.00 by Jan 30, 2025. The average Moolec Science Sa stock price prediction forecasts a potential upside of 334.78% from the current MLEC share price of $1.38.

(NASDAQ: MLEC) forecast ROE is N/A, which is considered weak.